Clinical Trials Sponsored by Junling Li
Total 932 results
-
Jun LiUnknown
-
Lei LiUnknownEndometriosis | Adenomyosis | Genomics | Metabolomics | Ectopic Endometrium | Eutopic Endometrium | TranscriptomicsChina
-
Lei LiUnknownOvarian Cancer | High Grade Serous Carcinoma | Prognosis | Early Diagnosis | ExosomesChina
-
Dr Foo Li LianUnknown
-
Hui LiWest China College of StomatologyCompletedMandibular Fractures
-
National Taiwan University HospitalYu-Li HospitalCompletedSchizophrenia | Schizoaffective Disorder | AgitationTaiwan
-
Lei LiRecruitingEpithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival PrognosisChina
-
Li ZhangHubei Cancer HospitalNot yet recruitingStage IV Non-small Cell Lung CancerChina
-
LI ChengNot yet recruitingRisk-Taking | Chronic Stress
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immune Checkpoint Inhibitors | Overall Survival | Anti-programmed Death-1 Antibody | Metastatic Cervical Carcinoma | Persistent Advanced Cervical Carcinoma | Objective Remission Rate | Progression-free Survival | Severe Adverse EventsChina
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Survival Outcomes | Targeted Therapy | Adverse Effect | Metastatic Cervical Carcinoma | Persistent Advanced Cervical CarcinomaChina
-
Lei LiRecruitingEpithelial Ovarian Cancer | High-grade Serous Ovarian Carcinoma | Survival Outcomes | Overall Survival | Progression-free Survival | Chromosomal Instability | Somatic Copy Number Distortion | Minimal Residual LesionsChina
-
Li Zhang, MDRecruitingSmall Cell Lung Cancer | Lung Cancer | DurvalumabChina
-
Li Zhang, MDRecruitingThe Diagnosis Was ALK Positive NSCLC | Second Generation ALK-TKI is Resistant | Efficacy of Ensatinib in This Subset of PatientsChina
-
Li Zhang, MDRecruitingCarcinoma, Non-Small-Cell LungChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Objective Response Rate | Overall Survival | Progression-free Survival | Epidermal Growth Factor Receptor | NimotuzumabChina
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Lei LiRecruitingQuality of Life | Cervical Cancer | Pelvic Floor Disorders | Survivorship | Overall Survival | Disease-free Survival | Urodynamics | Ovarian Reserve Function | Rectum Dynamics | Sex DysfunctionChina
-
Lei LiRecruitingLaparotomy | Laparoscopy | Locally Advanced Cervical Cancer | Neoadjuvant Chemotherapy | Adjuvant Therapy | Concurrent Chemoradiotherapy | Radical Hysterectomy | Objective Response | Systematic ChemotherapyChina
-
Lei LiRecruitingFebrile Neutropenia | Epithelial Ovarian Cancer | Adverse Event | Cost-effectiveness | Myelosuppression Adult | Colony Stimulating FactorsChina
-
Lei LiRecruitingColorectal Neoplasms, Hereditary Nonpolyposis | Hysterectomy | Hereditary Breast and Ovarian Cancer Syndrome | OvariectomyChina
-
Zhaoping LiCompletedPreDiabetesUnited States
-
Lei LiCompletedEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | Chinese | Homologous Recombination GenesChina
-
Lei LiUnknownEndometrial Cancer | Liquid Biopsy | DNA Methylation | Diagnostic Accuracy | Cervical Cytology | Training Set | Validation SetChina
-
Lei LiUnknownQuestionnaire | China | National Survey | Obstetrics and Gynecology | Workload | COVID-19 PandemicsChina
-
ShiYue LiUnknown
-
Lei LiUnknownDNA Methylation | Uterine Cervical Cancer | High Grade Squamous Intraepithelial Lesions | Low Grade Squamous Intraepithelial LesionsChina
-
Lei LiUnknownDNA Methylation | Uterine Cervical Cancer | High Grade Squamous Intraepithelial Lesions | Low Grade Squamous Intraepithelial LesionsChina
-
Lei LiUnknownOvarian High Grade Serous Carcinoma | Immune Repertoire | T Lymphocyte Receptor | B Lymphocyte ReceptorChina
-
Lei LiUnknownGynecologic Cancer | Chemotherapy-induced Nausea and VomitingChina
-
Lei LiUnknownEpithelial Ovarian Cancer | Progression-free Survival | Epithelial Ovarian Tumor of Borderline Malignancy | Driving MutationsChina
-
Lei LiUnknownCervical Adenocarcinoma | Human Papillomavirus | Metabolome | Prognosis | Whole Exome Sequencing | Tumorigenesis | Transcriptome | Genome-wide Association StudyChina
-
Lei LiUnknownColorectal Neoplasms, Hereditary Nonpolyposis | Endometrial NeoplasmsChina
-
Lei LiUnknownDeep Venous Thrombosis | Gynecologic Neoplasm | Ankle Motion | Abdominal BreathingChina
-
Jing LiUnknownInflammation | Hypertension | Diastolic Dysfunction
-
Nai Liang LiCompletedPostoperative Pain | Satisfaction | Quality of RecoveryTaiwan
-
JIANG Zhi-WeiCompletedGastrointestinal Stromal Tumor of StomachChina
-
JIANG Zhi-WeiCompleted
-
Nanjing Medical UniversityJinling Hospital, ChinaUnknownARDS | Intra-abdominal HypertensionSwitzerland
-
Suzhou Junjing BioSciences Co., Ltd.Sponsor GmbHNot yet recruitingLocally Advanced or Metastatic Malignant Solid TumorsChina
-
Jinling Hospital, ChinaMinistry of Health, ChinaCompleted
-
Chen LiRecruiting
-
Wen LiRecruitingUnresectable Hepatocellular CarcinomaChina
-
Guoxin LiNot yet recruiting
-
Luming LiBeijing Tsinghua Changgeng HospitalRecruitingSpinal Cord InjuriesChina
-
Yi Li, MDRecruitingSepsis-Associated EncephalopathyChina
-
Chen LiRecruitingPregnancy | Children Behavior ProblemChina